Premium
Sputum processing for evaluation of inflammatory mediators
Author(s) -
Kim JungSoo,
Hackley Grant H.,
Okamoto Kosuke,
Rubin Bruce K.
Publication year - 2001
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.1101
Subject(s) - sputum , myeloperoxidase , medicine , chronic bronchitis , dithiothreitol , cystic fibrosis , immunology , neutrophil elastase , inflammation , gastroenterology , enzyme , pathology , chemistry , biochemistry , tuberculosis
Neutrophil‐dominated inflammation is prominent in the cystic fibrosis (CF) and chronic bronchitis (CB) airways. We assessed the degree of airway inflammation by measuring the sputum concentrations of interleukin (IL)‐8, myeloperoxidase (MPO), and deoxyribonucleic acid (DNA). We determined the relationship among the concentrations of these mediators and investigated methodological problems that may be responsible for reported variability in measurements. Sputa obtained from 31 patients were solubilized with phosphate‐buffered saline, dithiothreitol (DTT) (0.1% or 1%), or dornase alfa (0.2 mg/mL). The sputum concentration of IL‐8 and MPO was measured by enzyme‐linked immunosorbent assay (ELISA), and DNA was measured using microfluorimetry. There was a significant relationship among sputum IL‐8, MPO, and DNA. For MPO (means ± SD), CF was 1,392 ± 771 vs. CB at 75 ± 65 mcg/mL; P < 0.0001. For IL‐8: CF was 239 ± 154 vs. CB at 121 ± 108 ng/mL; P = 0.0002. For DNA, CF was 1.707 ± 1.25 vs. CB at 0.184 ± 0.272 mg/mL; P < 0.0001. The MPO concentration in CF sputum was approximately double after in vitro treatment with dornase alfa ( P < 0.0001). There is a greater concentration of IL‐8, MPO, and DNA in CF than in CB sputa. There is a significant relationship among these inflammatory markers in sputum. DNA polymers bind myeloperoxidase in the sputum, and we speculate that treatment with dornase alfa may remove a source of MPO inhibition. Pediatr Pulmonol. 2001; 32:152–158. © 2001 Wiley‐Liss, Inc.